Nasser H. Hanna

Indiana University Health — United States

Medicine · Health Sciences

59h-index16.3kcitations469works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(215), Lung Cancer Research Studies(129), Lung Cancer Diagnosis and Treatment(117), Testicular diseases and treatments(98), Cancer Immunotherapy and Biomarkers(45)

Publications468 total

Management of Central Nervous System Progression With Dose-Escalated Lorlatinib in ALK-Positive NSCLC: A Report of 2 Cases and Literature Review
Clinical Lung Cancer·2025
Comprehensive Genomic Profiling of Rare Lung Tumors: Adenosquamous Carcinoma and Pulmonary Carcinosarcoma
Journal of Thoracic Oncology·2025
Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081
Journal for ImmunoTherapy of Cancer·2025· 5 citedOpen Access
In the Era of Neoadjuvant Chemoimmunotherapy, is There a Role for Radiation Intensification Therapy in Patients With Stage III (N2) Non-Small Cell Lung Cancer (NSCLC) Who Undergo Surgery? Results of LUN17-321 in the Context of Current Clinical Treatment Options
Clinical Lung Cancer·2025
Clinical characteristics and outcomes of metastatic germ cell tumors with highly elevated human chorionic gonadotropin levels.
Journal of Clinical Oncology·2025· 1 cited
Supervised home-based exercise in patients with advanced non-small cell lung cancer (NSCLC) on maintenance immune checkpoint inhibitors (ICI).
Journal of Clinical Oncology·2025
TROP-2 expression in germ cell tumors (GCT).
Journal of Clinical Oncology·2025
Evaluating inflammatory biomarkers as predictors of outcomes and immune-related adverse events (irAE) in the Big Ten Cancer Research Consortium (BTCRC) LUN16-081 phase II clinical trial.
Journal of Clinical Oncology·2025
Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening
American Society of Clinical Oncology Educational Book·2025· 2 cited
Management of relapsed primary retroperitoneal (RP) germ-cell tumor (GCT) after front-line chemotherapy.
Journal of Clinical Oncology·2025
Prediction Model for Brain Metastasis in Patients With Metastatic Germ‐Cell Tumors
Cancer Medicine·2025Open Access
Correlates of Perceived Illness Severity and Terminality in Advanced Lung and Prostate Cancer
Journal of Pain and Symptom Management·2025
Association of Immune-Related Adverse Events With Efficacy in Consolidation Nivolumab Plus Ipilimumab or Nivolumab Alone After Chemoradiation in Patients With Unresectable Stage III Nonsmall Cell Lung Cancer: An Exploratory Analysis From the Big 10 Cancer Research Consortium Study BTCRC LUN 16-081
Clinical Lung Cancer·2024· 3 cited
Response to Letter to the Editor
Journal of Thoracic Oncology·2024· 1 cited
Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors
Lung Cancer·2024· 1 cited
RADT-46. RADIOSURGERY DOSE REDUCTION FOR BRAIN METASTASES ON IMMUNOTHERAPY (RADREMI):A PROSPECTIVE PILOT STUDY
Neuro-Oncology·2024Open Access
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics·2024· 5 cited
The SMILE scale: a wellness behavioral tool for patients with cancer
Quality of Life Research·2024
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study
Lung Cancer·2024· 5 cited
PP01.39 Demographic and Socioeconomic Disparities in Lung Cancer Screening Uptake: A Quantitative Analysis in the State of Indiana
Journal of Thoracic Oncology·2024Open Access
page 1 of 24Next →

Frequent Co-authors

Lawrence H. Einhorn(14), Shadia I. Jalal(6), Frances A. Shepherd(5), Paul A. Bunn(5), Peter Ellis(5), Rafael Rosell(5), Frank V. Fossella(4), Filippo de Marinis(4), Joachim von Pawel(4), Rafat Ansari(4), David H. Johnson(4), Sarah Temin(4), Joan H. Schiller(4), Gregory A. Masters(4), Ramaswamy Govindan(4), Pasi A. Jänne(4), Catherine E. Mosher(4), Victoria L. Champion(4), Christian Manegold(3), Sofia Paul(3)